Academic Entrepreneurship
The investigators at CMM are committed to strive for clinical translation and academic entrepreneurship to increase the impact of their fundamental science discoveries. Spin-off companies within CMM are:
CLEARA Biotech
Mission: Targeting cellular senescence to extend human healthspan at old age and to counteract therapy resistance in late stage cancer.
Cyclomics
Mission: transform cancer care by enabling faster and more reliable diagnoses, particularly in the context of cancer recurrence thanks to its proprietary circulating tumor DNA (ctDNA) detection technology.
Laigo Bio
Mission: Developing first-in-class anti-cancer therapeutics that remove and degrade cancer-promoting cell surface proteins, rather than simply blocking them.